Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

By Rogers S.L.   Doody R.S.   Pratt R.D.   Ieni J.R.  

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification

By Sobel B.-F.X.   Sigmon S.C.   Walsh S.L.   Johnson R.E.   Liebson I.A.   Nuwayser E.S.   Kerrigan J.H.   Bigelow G.E.  

Drug and Alcohol Dependence, Vol. 73, Iss. 1, 2004-01 ,pp. : 11-22

Elsevier

Access to resources Recommend Favorite

Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence

By Knapp Clifford M.   Sarid-Segal Ofra   Richardson Mark A.   Colaneri Laurie Sickles   Afshar Maryam   Devine Eric   Streeter Chris C.   Piechniczek-Buczek Joanne   Ciraulo Domenic A.  

The American Journal of Drug and Alcohol Abuse, Vol. 36, Iss. 2, 2010-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

By Rogers S.L.   Friedhoff L.T.  

European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. : 67-75

Elsevier

Access to resources Recommend Favorite

Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder: A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial

By Han Changsu   Pae Chi-Un   Lee Bun-Hee   Ko Young-Hoon   Masand Prakash S.   Patkar Ashwin A.   Joe Sook-Haeng   Jung In-Kwa  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite